Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/3709| Title: | More options for managing severe asthma in adults | Authors: | Chang, Anne Beasley, R. |
Issue Date: | 2021 | Source: | 9, (1), 2021, p. 3-5 | Pages: | 3-5 | Journal: | The Lancet Respiratory Medicine | Abstract: | L20105424702021-01-19 | DOI: | 10.1016/S2213-2600(20)30398-2 | Resources: | https://www.embase.com/search/results?subaction=viewrecord&id=L2010542470&from=exporthttp://dx.doi.org/10.1016/S2213-2600(20)30398-2 | | Keywords: | note;odds ratio;prescription;priority journal;severe asthma;muscarinic receptor blocking agent;antiasthmatic agentbeclometasone dipropionate plus formoterol fumarate plus glycopyrronium bromide;beta 2 adrenergic receptor stimulating agent;corticosteroid;fluticasone furoate plus umeclidinium plus vilanterol;long acting drug;transcription factor RUNX2;confidence interval;drug efficacy;drug industry;eosinophil;forced expiratory volume;fractional exhaled nitric oxide;human;intention to treat analysis | Type: | Article |
| Appears in Sites: | Children's Health Queensland Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.